Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Elion Raises $9.3M for Healthcare AI Research and Intelligence

    7. August 2025

    Doctors decry RFK Jr decision to slash mRNA vaccine grants: ‘Our nation will pay in lives’

    7. August 2025

    BD commits $35M to expand US syringe production plant

    6. August 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»OpenEvidence Secures $210M, Launches Free AI Agent for Clinicians
    News

    OpenEvidence Secures $210M, Launches Free AI Agent for Clinicians

    HealthradarBy Healthradar17. Juli 2025Keine Kommentare4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    OpenEvidence Secures 0M, Launches Free AI Agent for Clinicians
    Share
    Facebook Twitter LinkedIn Pinterest Email


    OpenEvidence Secures 0M, Launches Free AI Agent for Clinicians

    What You Should Know: 

    – OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians raises $210M in Series B funding round, valuing the company at $3.5 billion. The round was co-led by Google Ventures and Kleiner Perkins, with follow-on investment from Series A leader Sequoia Capital, and additional participation from Coatue, Conviction, and Thrive. OpenEvidence has now raised over $300M since its founding.

    – OpenEvidence is rapidly transforming how frontline healthcare providers access, evaluate, and apply the world’s medical knowledge, helping clinicians make high-stakes clinical decisions at the point of care.

    Solving Information Overload with Real-Time Evidence

    Clinicians are overwhelmed by information overload, with the volume of medical research doubling every five years. Traditional medical evidence databases are slow, fragmented, and require extensive manual searching, pulling physicians away from patient care.

    OpenEvidence addresses this by allowing clinicians to “search once, skip the scavenger hunt, and surface the science in seconds”. Through strategic content partnerships with institutions like the American Medical Association (JAMA) and The New England Journal of Medicine, OpenEvidence provides point-of-care answers grounded in the latest research, complete with references and follow-up suggestions. OpenEvidence’s HIPAA-compliant platform rapidly synthesizes medical research, enabling faster, more evidence-based decisions and improved patient outcomes by reducing the lag between new evidence and bedside application.

    Launching DeepConsult™: The First AI Agent for Physicians

    In addition to the funding announcement, OpenEvidence announced the wide release of OpenEvidence DeepConsult™, the first AI agent purpose-built for physicians. DeepConsult provides every physician with a personal, private team of PhD-level, medically-specialized AI agents capable of conducting advanced medical research autonomously.

    These DeepConsult agents use advanced reasoning models to analyze and cross-reference hundreds of peer-reviewed medical studies in parallel, surfacing not just direct answers but also novel, cross-cutting connections that might otherwise go unnoticed. This results in an evidence-based synthesis—an integrative, interdisciplinary understanding distilled from hundreds of studies that would typically take a human researcher months to produce for a single clinical topic.

    While OpenEvidence’s core search product focuses on speed (5–10 second answers), DeepConsult addresses a different use case: providing comprehensive research reports for complex questions when physicians have more time, such as during a lunch break. This marks a new era of medical productivity with tireless, agentic assistants.

    Despite DeepConsult runs requiring over 100 times the compute and cost of a standard search, OpenEvidence is offering it entirely free to all verified U.S. clinicians, regardless of their institution or workplace, underscoring its mission to support physicians at the point of care.

    Growth and Clinical Adoption

    OpenEvidence is actively used across more than 10,000 hospitals and medical centers nationwide and by over 40% of physicians in the United States who log in daily. The platform continues to grow by over 65,000 new verified U.S. clinician registrations each month.

    The company has seen exponential growth: in July 2024, OpenEvidence supported approximately 358,000 logged-in, verified U.S. physician consultations in one month. One year later, OpenEvidence now handles that many consultations each workday, supporting over 8,500,000 clinical consultations by logged-in, verified U.S. physicians per month—a 2,000%+ year-over-year growth rate. More than 100 million Americans this year will be treated by a doctor who used OpenEvidence.

    Expansion Plans

    OpenEvidence, founded by Harvard- and MIT-trained PhDs Daniel Nadler and Zachary Ziegler, will use the new funding to expand strategic content partnerships that enhance its library of advanced medical knowledge. Daniel Nadler, founder of Kensho (acquired by S&P Global for $700 million in 2018), was also named to the TIME100 Health list of the 100 Most Influential People in global health in 2025. Robert M. Wachter, MD, Chair of Medicine at UCSF, lauded the partnership with the American Medical Association as a significant step towards fulfilling the promise of trusted, evidence-based clinical decision support.



    Source link

    210M Agent Artificial Intelligence clinicians Free Launches OpenEvidence Secures
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleEU, Canada delay retaliatory tariffs against US
    Next Article Researchers announce babies born from a trial of three-person IVF
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Elion Raises $9.3M for Healthcare AI Research and Intelligence

    7. August 2025
    News

    BD commits $35M to expand US syringe production plant

    6. August 2025
    News

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20257 Views

    How nanoplastics may be impacting our long-term health

    27. Juli 20254 Views

    Whoop wants everyone to give a whoop about the new Whoop 5.0

    1. Juni 20254 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    New surgeon general nominee cofounded a16z backed health app with DOGE operative

    1. Juni 20257 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20257 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.